Luca Gambini
Affiliations: | 2015-2016 | Chemistry | University of California, Riverside, Riverside, CA, United States |
Google:
"Luca Gambini"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baggio C, Udompholkul P, Gambini L, et al. (2022) Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2. Journal of Medicinal Chemistry |
| Udompholkul P, Baggio C, Gambini L, et al. (2021) Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein. Journal of Medicinal Chemistry. 64: 16147-16158 |
| Udompholkul P, Baggio C, Gambini L, et al. (2021) Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates. Molecules (Basel, Switzerland). 26 |
| Gambini L, Udompholkul P, Baggio C, et al. (2021) Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1. Journal of Medicinal Chemistry. 64: 4903-4912 |
| Gambini L, Udompholkul P, Salem AF, et al. (2020) Stability and cell permeability of sulfonyl fluorides in the design of Lys-covalent antagonists of protein-protein interactions. Chemmedchem |
| Barile E, Baggio C, Gambini L, et al. (2020) Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming. Molecules (Basel, Switzerland). 25 |
| Salem AF, Gambini L, Udompholkul P, et al. (2020) Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents. Pharmaceuticals (Basel, Switzerland). 13 |
| Baggio C, Udompholkul P, Gambini L, et al. (2020) N-locking stabilization of covalent helical peptides: Application to Bfl-1 antagonists. Chemical Biology & Drug Design |
| Baggio C, Udompholkul P, Gambini L, et al. (2019) Aryl-fluorosulfate-based Lysine Covalent pan-Inhibitors of Apoptosis Proteins (IAP) Antagonists with Cellular Efficacy. Journal of Medicinal Chemistry |
| Gambini L, Baggio C, Udompholkul P, et al. (2019) Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues. Journal of Medicinal Chemistry |